Perspectives of South Korean Parents Toward Psychotropic Medication Use Among Autistic Individuals.
Saved in:
| Title: | Perspectives of South Korean Parents Toward Psychotropic Medication Use Among Autistic Individuals. |
|---|---|
| Authors: | Kim, Kyung Mee (AUTHOR), Lee, Chung Eun (AUTHOR), Park, Yong-Moon Mark (AUTHOR), Han, Kyungdo (AUTHOR), Cho, In Young (AUTHOR) |
| Source: | Journal of Autism & Developmental Disorders. Sep2026, Vol. 56 Issue 9, p3629-3642. 14p. |
| Subjects: | Therapeutics, Qualitative research, Research funding, Autism, Interviewing, Parent attitudes, Descriptive statistics, Attitude (Psychology), Thematic analysis, Communication, Psychology of parents, Asperger's syndrome, Stakeholder analysis, Psychiatric drugs, Inter-observer reliability |
| Geographic Terms: | South Korea |
| Abstract: | This study aimed to understand the status of psychotropic medication use among autistic individuals and how South Korean parents perceive its effects and the associated communication processes. This study involved three research questions investigating the following: general prescription trends of psychotropic medication use among autistic individuals, psychotropic medication use and its effects, and the communication of psychotropic medication use with stakeholders. This study employed a qualitative design and involved individual interviews with 19 parents of autistic individuals. To be included in the study, participants were required to have a child with autism over 18 years of age, currently receiving psychotropic medication. Constant comparative analysis and emergent coding were used to analyze the data. The general prescription trends of psychotropic medication use were grouped according to age based on the initiation of psychotropic medication use, reasons for psychotropic medication use, dose of psychotropic medication use, and experience of psychiatric hospitalization. Overall, parents were skeptical of the effects of psychotropic medications, leading to non-adherence to the prescribed psychotropic medications. Finally, there was a lack of communication among psychiatrists, autistic adults, and other professionals regarding psychotropic medication use. Future practices are warranted to develop educational programs on medication use, including foundational knowledge on medications, correct dosages, and strategies for managing side effects. Furthermore, ongoing communication among stakeholders should be guaranteed based on team approaches while prioritizing the voices of autistic individuals. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
